Literature DB >> 29948594

Complete Atrioventricular Block in an Elderly Patient Treated with Low-Dose Lacosamide.

Célia Lachuer1, Jennifer Corny2, Yvonnick Bézie2, Sadri Ferchichi3, Bernard Durand-Gasselin3.   

Abstract

Lacosamide, one of the last antiepileptic drugs marketed, can cause extension of PR interval. Precautions are recommended when used in elderly and with other drugs extending PR interval. Cases of severe third-degree atrioventricular block have been reported only in post-marketing case reports when used at high-doses and remain rare. We report the case of an 88-year-old woman treated with bisoprolol, who experienced a complete atrioventricular block after initiation of lacosamide for epilepsy associated with neurodegenerative disease. This dramatic event required a pacemaker implementation. Not being dose-dependent (initiation dosage used), it seemed partially explained by drug-drug interaction with bisoprolol.

Entities:  

Keywords:  Cardiac side effect; Geriatrics; Heart block; Lacosamide

Mesh:

Substances:

Year:  2018        PMID: 29948594     DOI: 10.1007/s12012-018-9467-x

Source DB:  PubMed          Journal:  Cardiovasc Toxicol        ISSN: 1530-7905            Impact factor:   3.231


  4 in total

1.  Lacosamide Associated Complete Heart Block in Elderly.

Authors:  Indu Ghanshyam Bhana; Mahendra Chourasiya; Soaham Dilip Desai
Journal:  Ann Indian Acad Neurol       Date:  2019-10-25       Impact factor: 1.383

2.  Evaluation of Cardiovascular Concerns of Intravenous Lacosamide Therapy in Epilepsy Patients.

Authors:  Yan-Ting Lu; Chih-Hsiang Lin; Chen-Jui Ho; Che-Wei Hsu; Meng-Han Tsai
Journal:  Front Neurol       Date:  2022-07-04       Impact factor: 4.086

Review 3.  Seizures associated with coronavirus infections.

Authors:  Ali A Asadi-Pooya
Journal:  Seizure       Date:  2020-05-11       Impact factor: 3.184

Review 4.  Lacosamide-Related Arrhythmias: A Systematic Analysis and Review of the Literature.

Authors:  Ruchi Yadav; Ezra Schrem; Vivek Yadav; Amog Jayarangaiah; Sushruth Das; Pramod Theetha Kariyanna
Journal:  Cureus       Date:  2021-12-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.